• End date
    Dec 31, 2022
  • participants needed
  • sponsor
    Abbott Medical Devices
Updated on 12 July 2020
Mira Tissari
Primary Contact
Kliniken der Friedrich-Alexander-Universitat (8.7 mi away) Contact
+31 other location


The purpose of this clinical investigation is to characterize the procedural safety and device performance of transfemoral implantation of the Portico Transcatheter Aortic Heart Valve in patients with symptomatic degenerative aortic stenosis.


The CONFIDENCE registry study will be conducting as a prospective, non-randomized, observational, single-arm, multi-center study.

Approximately 1000 subjects with severe symptomatic (NYHA class II) aortic stenosis (AS), will undergo Portico Transcatheter Aortic Heart Valve implantation.

The subject data will be collected at baseline, index procedure, pre- discharge, 30 days and 12 months from the index procedure.

Treatment Portico™ Valve, Delivery System(s) and Loading Systems(s)
Clinical Study IdentifierNCT03752866
SponsorAbbott Medical Devices
Last Modified on12 July 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.


Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have any of these conditions: Symptomatic Degenerative Aortic Stenosis or Severe Aortic Stenosis?
Subjects who are >18 years of age or legal age in host country and have been identified as a candidate for a Portico valve implant
Subjects who have been informed of the nature of the study, agree to its provisions and have provided written informed consent as approved by the Ethics Committee (EC) of the respective clinical center

Exclusion Criteria

Candidates will be excluded if any of the following conditions are present
Have sepsis, including active endocarditis
Have any evidence of left ventricular or atrial thrombus
Have vascular conditions (i.e. caliber, stenosis, tortuosity, or severe calcification) that make insertion and endovascular access to the aortic valve improbable
Have a non-calcified aortic annulus
Have congenital bicuspid or unicuspid leaflet configuration
Are unable to tolerate antiplatelet/anticoagulant therapy
Are pregnant at the time of signing informed consent
Are currently participating in a drug or device study that may impact the registry (unless prior sponsor approval for co-enrollment is granted)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer


user name

Annotated by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No made yet